Serial #86538589
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86538589 Trademark

Serial Number: 86538589 • Registration: 4925241

Serial #86538589 is a trademark filed by The Translational Genomics Research Institute on February 18, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

The Translational Genomics Research Institute (42 trademarks)

Phoenix, AZ 85004

Entity Type: 03

ASHION ANALYTICS, LLC (6 trademarks)

PHOENIX, AZ 85004

Entity Type: 16

Trademark Details

Filing Date

February 18, 2015

Registration Date

March 29, 2016

Published for Opposition

January 12, 2016

Goods & Services

[Consulting services in the nature of providing information about medical education; Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical and genetic conditions; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and genetics field; Education services, namely, providing training programs in the field of genetics; Conducting workshops and seminars in genetic testing and disease identification and treatment; Organization of seminars, working groups, research groups and conventions in the fields of medicine, genetics and scientific research; On-line journals, namely, blogs featuring commentary and information in the fields of DNA identification techniques, practices, and tools; Organization of conferences and symposia for the discussion, dissemination and exchange of scientific data and ideas on topics of interest to the scientific community; Providing educational demonstrations regarding biology, molecular biology, genetics, DNA sequencing and bioinformatics; Conducting educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics; Conducting classes, seminars and workshops in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course materials in connection therewith; Educational services, namely, conducting educational programs in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Organizing exhibitions for education in biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Providing courses of instruction in the fields of biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course material in connection therewith; Teaching in the fields of biology, molecular biology, genetics, genomics, DNA sequencing and bioinformatics and nature study]

[Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties]

[Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use]

Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical and research purposes; Consulting services in the nature of providing medical information; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling; Genetic testing for medical diagnostic purposes; Genomic testing for medical diagnostic purposes

Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; [Consulting services in the field of pharmaceutical research and development and laboratory testing;] Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of oncology; [Medical and scientific research in the field of genetics and genetic engineering;] Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials; Diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; DNA-sequencing for scientific research purposes; [Targeted pharmaceutical drug development services;] Genotyping; Gene screening; Gene isolation and gene expression analysis for scientific research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research purposes

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 29, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 10, 2022 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 10, 2022 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 16, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 8, 2022 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 8, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 8, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2021 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 15, 2021 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 29, 2021 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 15, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 29, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 24, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 10, 2015 PREV
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Dec 5, 2015 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2015 CNSA
USE AMENDMENT ACCEPTED
Dec 4, 2015 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Nov 26, 2015 AUPC
USE AMENDMENT FILED
Nov 26, 2015 IUAF
TEAS AMENDMENT OF USE RECEIVED
Nov 25, 2015 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2015 CRFA
ASSIGNED TO LIE
Nov 13, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2015 CNRT
ASSIGNED TO EXAMINER
May 26, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 5, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2015 NWOS
NEW APPLICATION ENTERED
Feb 21, 2015 NWAP